HCFA Clinical Lab Test Payments Should Defer To NLA Levels, IoM Says
This article was originally published in The Gray Sheet
Executive Summary
Medicare outpatient clinical laboratory payments should be set at the current national limitation amounts (NLAs), pending development of a resource-based relative value scale, the Institute of Medicine advises in a recent report.
You may also be interested in...
CMS Lab Public Meeting Discussion Centers On Payment Policy Issues
Inherent reasonableness (IR) is one mechanism CMS likely will employ to lab test payment rates far below the national limitation amount in certain regions, according to Ambulatory Services Division Director Don Thompson
CMS Lab Public Meeting Discussion Centers On Payment Policy Issues
Inherent reasonableness (IR) is one mechanism CMS likely will employ to lab test payment rates far below the national limitation amount in certain regions, according to Ambulatory Services Division Director Don Thompson
Rep. Dunn’s National Lab Test Fee Schedule Resurfaces In 108th
CMS should urge stakeholder participation in an annual meeting to determine payment amounts for Medicare clinical diagnostic laboratory tests, a bill sponsored by Rep. Jennifer Dunn (R-Wash.) states